Related news for:   Dr Andrew Swayne

Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia gravis

06

Dec

New applications of drugs could reduce side effects for Myasthenia gravis patients

Mater's Neurosciences Unit are investigating novel diagnostic markers for autoimmune encephalitis

07

Aug

NMDAR antibody encephalitis and novel diagnostic markers

The Betty McGrath Fellowship enables practising Mater clinicians or other health professionals to increase their research activity by providing salary support to back-fill their positions.

24

Oct

Betty McGrath Fellowship recipient’s announced for 2017